Since runx1 recombinant protein was approved to ameliorate the disc degeneration scenario, whether combined with genetically modified MSCs using Cre/LoxP gene-editing system can sustain the runx1 expression and facilitate the seriously damaged disc healing rate is yet to be explored. Here, RUNX1 is linked to intervertebral disk degenerative disorder.